EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Loganin Ameliorates Cholestatic Liver Fibrosis by Inhibiting Hepatic Stellate Cell Autophagy and Activation Through EGFR Signaling

Xinwen Li iD, Huiling Zhang iD, Chao Zhang iD, Xiaomin Zhang iD, Jiefeng He iD

Mediators of Inflammation · 2026-01 · 2026 (1)

DOI: 10.1155/mi/7967581 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mediators of Inflammation, online erschienen am 17.08.2026. Verfasst von Xinwen Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical Univers…. Hauptthemen laut MEDLINE: Hepatic Stellate Cells, Autophagy, Liver Cirrhosis, ErbB Receptors. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liver cirrhosis represents the irreversible end‐stage of various chronic liver diseases, whereas hepatic fibrosis, characterized by hepatic stellate cell (HSC) activation, constitutes the critical pathological intermediate in this progression. In this study, we investigated the antifibrotic effects of loganin, a natural iridoid glycoside, and elucidated its underlying mechanisms in bile duct ligation (BDL)–induced cholestatic liver injury and hepatic fibrosis and in TGF‐β1–stimulated HSCs. Sprague–Dawley rats subjected to BDL surgery received loganin for 14 days, resulting in marked amelioration of hepatomegaly, inflammatory infiltration, hepatocyte necrosis, and collagen deposition, alongside restoration of serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), and total bilirubin (T‐BIL) levels and suppression of fibrogenic gene expression (collagen type I alpha 1 chain [COL1α1], alpha‐smooth muscle actin [α‐SMA], and fibronectin). Moreover, loganin attenuated hepatic autophagy, as evidenced by reduced Beclin‐1 expression and LC3B‐II/I ratio, with decreased colocalization of α‐SMA and LC3B. Bioinformatics analysis and molecular docking indicated that epidermal growth factor receptor (EGFR) may be the target protein through which loganin exerts its antifibrotic effect. Experimental validation demonstrated that loganin suppressed BDL‐induced EGFR phosphorylation in vivo. In TGF‐β1–activated HSC‐T6 cells, loganin inhibited cell activation, downregulated fibrosis markers, impaired autophagic flux, and suppressed TGF‐β1–induced upregulation of Beclin‐1 and LC3B‐II/I. Critically, cotreatment with the EGFR agonist EGF reversed the autophagy‐inhibitory and antifibrotic effects of loganin, whereas the EGFR inhibitor AG‐1478 mimicked loganin’s actions, confirming EGFR signaling as the functional mediator. Overall, these results indicated that loganin could alleviate liver injury and hepatic fibrosis in BDL rats by inhibiting autophagy and activation of HSCs, and this protective effect is mediated by the EGFR pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatic Stellate CellsAutophagyLiver CirrhosisErbB ReceptorsIridoidsCholestasisAnimalsRats, Sprague-DawleyRatsMaleSignal TransductionTransforming Growth Factor beta1

Stichwörter der Autor:innen

EGFRautophagyhepatic stellate cellsliver fibrosisloganin

Substanzen

ErbB ReceptorsIridoidsloganinTransforming Growth Factor beta1

Autor:innen und Institutionen

  • Department of Pharmacy, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan 030032, China.
  • Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China, hust.edu.cn.
  • Department of Gastroenterology, Shanxi Provincial People's Hospital, Taiyuan, China, spph-sx.com.
  • Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan 030032, China.
  • Department of Hepatobiliary Surgery, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan 030032, China.

ORCID-Profile: Xinwen Li, Huiling Zhang, Chao Zhang, Xiaomin Zhang, Jiefeng He

Zitieren

APA

Li, X., Zhang, H., Zhang, C., Zhang, X., & He, J. (2026). Loganin Ameliorates Cholestatic Liver Fibrosis by Inhibiting Hepatic Stellate Cell Autophagy and Activation Through EGFR Signaling. Mediators of Inflammation, 2026(1). https://doi.org/10.1155/mi/7967581

Vancouver

Li X, Zhang H, Zhang C, Zhang X, He J. Loganin Ameliorates Cholestatic Liver Fibrosis by Inhibiting Hepatic Stellate Cell Autophagy and Activation Through EGFR Signaling. Mediators of Inflammation. 2026;2026(1). doi:10.1155/mi/7967581

BibTeX
@article{Li2026,
  author = {Li, Xinwen and Zhang, Huiling and Zhang, Chao and Zhang, Xiaomin and He, Jiefeng},
  title = {Loganin Ameliorates Cholestatic Liver Fibrosis by Inhibiting Hepatic Stellate Cell Autophagy and Activation Through EGFR Signaling},
  journal = {Mediators of Inflammation},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/mi/7967581}
}
Kostenlos starten →